Serum calcium values in term and late-preterm neonates receiving gentamicin

Arpitha Chiruvolu, William D. Engle, Dorothy Sendelbach, M. Denise Manning, Gregory L. Jackson

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Since noting an apparent increase in hypocalcemia in neonates receiving gentamicin every 24 h (q 24 h) for >4 days, we have prospectively monitored serum calcium (Ca) values in these patients receiving prolonged gentamicin therapy. This study is a retrospective analysis of those values measured during gentamicin treatment. The study included neonates with gestational age >35 weeks who received >4 days of gentamicin therapy and in whom at least one serum Ca value was measured >47 h after initiation of therapy. Hypocalcemia was defined as a serum Ca level <8 mg/dl (2 mmol/l). Data were analyzed by Student t-test, chi-square test, and Pearson product moment correlation. There were 1,624 neonates that met the study criteria. Ca was <8 mg/dl in 241 (15%). Ca <8 mg/dl was more likely in boys than in girls (16.4% vs 11.8%, P=0.01) and in neonates <37 weeks gestational age (GA) than in those ≤37 weeks GA (23.9% vs 14.1%, P=0.01). A second Ca value was obtained in 883 neonates (54%); 23.2% of neonates with initial Ca <8 mg/dl remained hypocalcemic, and 30% of these were receiving oral Ca supplementation. The second Ca value was <8 mg/dl in eight neonates in whom initial Ca was >8 mg/dl. Hypocalcemia is not uncommon in neonates receiving gentamicin therapy, and it may occur more frequently in boys and late-preterm infants. These data suggest that the monitoring of serum Ca levels should be considered when gentamicin is given >4 days.

Original languageEnglish (US)
Pages (from-to)569-574
Number of pages6
JournalPediatric Nephrology
Volume23
Issue number4
DOIs
StatePublished - Apr 2008

Fingerprint

Gentamicins
Newborn Infant
Calcium
Hypocalcemia
Serum
Therapeutics
Premature Infants
Gestational Age

Keywords

  • Antibiotics
  • Gentamicin
  • Neonate
  • Renal calcium excretion
  • Renal function
  • Serum calcium

ASJC Scopus subject areas

  • Nephrology
  • Pediatrics, Perinatology, and Child Health

Cite this

Serum calcium values in term and late-preterm neonates receiving gentamicin. / Chiruvolu, Arpitha; Engle, William D.; Sendelbach, Dorothy; Manning, M. Denise; Jackson, Gregory L.

In: Pediatric Nephrology, Vol. 23, No. 4, 04.2008, p. 569-574.

Research output: Contribution to journalArticle

Chiruvolu, Arpitha ; Engle, William D. ; Sendelbach, Dorothy ; Manning, M. Denise ; Jackson, Gregory L. / Serum calcium values in term and late-preterm neonates receiving gentamicin. In: Pediatric Nephrology. 2008 ; Vol. 23, No. 4. pp. 569-574.
@article{f1bad32cf0bc463a9d7471a8ff1f386d,
title = "Serum calcium values in term and late-preterm neonates receiving gentamicin",
abstract = "Since noting an apparent increase in hypocalcemia in neonates receiving gentamicin every 24 h (q 24 h) for >4 days, we have prospectively monitored serum calcium (Ca) values in these patients receiving prolonged gentamicin therapy. This study is a retrospective analysis of those values measured during gentamicin treatment. The study included neonates with gestational age >35 weeks who received >4 days of gentamicin therapy and in whom at least one serum Ca value was measured >47 h after initiation of therapy. Hypocalcemia was defined as a serum Ca level <8 mg/dl (2 mmol/l). Data were analyzed by Student t-test, chi-square test, and Pearson product moment correlation. There were 1,624 neonates that met the study criteria. Ca was <8 mg/dl in 241 (15{\%}). Ca <8 mg/dl was more likely in boys than in girls (16.4{\%} vs 11.8{\%}, P=0.01) and in neonates <37 weeks gestational age (GA) than in those ≤37 weeks GA (23.9{\%} vs 14.1{\%}, P=0.01). A second Ca value was obtained in 883 neonates (54{\%}); 23.2{\%} of neonates with initial Ca <8 mg/dl remained hypocalcemic, and 30{\%} of these were receiving oral Ca supplementation. The second Ca value was <8 mg/dl in eight neonates in whom initial Ca was >8 mg/dl. Hypocalcemia is not uncommon in neonates receiving gentamicin therapy, and it may occur more frequently in boys and late-preterm infants. These data suggest that the monitoring of serum Ca levels should be considered when gentamicin is given >4 days.",
keywords = "Antibiotics, Gentamicin, Neonate, Renal calcium excretion, Renal function, Serum calcium",
author = "Arpitha Chiruvolu and Engle, {William D.} and Dorothy Sendelbach and Manning, {M. Denise} and Jackson, {Gregory L.}",
year = "2008",
month = "4",
doi = "10.1007/s00467-007-0707-8",
language = "English (US)",
volume = "23",
pages = "569--574",
journal = "Pediatric Nephrology",
issn = "0931-041X",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Serum calcium values in term and late-preterm neonates receiving gentamicin

AU - Chiruvolu, Arpitha

AU - Engle, William D.

AU - Sendelbach, Dorothy

AU - Manning, M. Denise

AU - Jackson, Gregory L.

PY - 2008/4

Y1 - 2008/4

N2 - Since noting an apparent increase in hypocalcemia in neonates receiving gentamicin every 24 h (q 24 h) for >4 days, we have prospectively monitored serum calcium (Ca) values in these patients receiving prolonged gentamicin therapy. This study is a retrospective analysis of those values measured during gentamicin treatment. The study included neonates with gestational age >35 weeks who received >4 days of gentamicin therapy and in whom at least one serum Ca value was measured >47 h after initiation of therapy. Hypocalcemia was defined as a serum Ca level <8 mg/dl (2 mmol/l). Data were analyzed by Student t-test, chi-square test, and Pearson product moment correlation. There were 1,624 neonates that met the study criteria. Ca was <8 mg/dl in 241 (15%). Ca <8 mg/dl was more likely in boys than in girls (16.4% vs 11.8%, P=0.01) and in neonates <37 weeks gestational age (GA) than in those ≤37 weeks GA (23.9% vs 14.1%, P=0.01). A second Ca value was obtained in 883 neonates (54%); 23.2% of neonates with initial Ca <8 mg/dl remained hypocalcemic, and 30% of these were receiving oral Ca supplementation. The second Ca value was <8 mg/dl in eight neonates in whom initial Ca was >8 mg/dl. Hypocalcemia is not uncommon in neonates receiving gentamicin therapy, and it may occur more frequently in boys and late-preterm infants. These data suggest that the monitoring of serum Ca levels should be considered when gentamicin is given >4 days.

AB - Since noting an apparent increase in hypocalcemia in neonates receiving gentamicin every 24 h (q 24 h) for >4 days, we have prospectively monitored serum calcium (Ca) values in these patients receiving prolonged gentamicin therapy. This study is a retrospective analysis of those values measured during gentamicin treatment. The study included neonates with gestational age >35 weeks who received >4 days of gentamicin therapy and in whom at least one serum Ca value was measured >47 h after initiation of therapy. Hypocalcemia was defined as a serum Ca level <8 mg/dl (2 mmol/l). Data were analyzed by Student t-test, chi-square test, and Pearson product moment correlation. There were 1,624 neonates that met the study criteria. Ca was <8 mg/dl in 241 (15%). Ca <8 mg/dl was more likely in boys than in girls (16.4% vs 11.8%, P=0.01) and in neonates <37 weeks gestational age (GA) than in those ≤37 weeks GA (23.9% vs 14.1%, P=0.01). A second Ca value was obtained in 883 neonates (54%); 23.2% of neonates with initial Ca <8 mg/dl remained hypocalcemic, and 30% of these were receiving oral Ca supplementation. The second Ca value was <8 mg/dl in eight neonates in whom initial Ca was >8 mg/dl. Hypocalcemia is not uncommon in neonates receiving gentamicin therapy, and it may occur more frequently in boys and late-preterm infants. These data suggest that the monitoring of serum Ca levels should be considered when gentamicin is given >4 days.

KW - Antibiotics

KW - Gentamicin

KW - Neonate

KW - Renal calcium excretion

KW - Renal function

KW - Serum calcium

UR - http://www.scopus.com/inward/record.url?scp=40549137807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40549137807&partnerID=8YFLogxK

U2 - 10.1007/s00467-007-0707-8

DO - 10.1007/s00467-007-0707-8

M3 - Article

C2 - 18219496

AN - SCOPUS:40549137807

VL - 23

SP - 569

EP - 574

JO - Pediatric Nephrology

JF - Pediatric Nephrology

SN - 0931-041X

IS - 4

ER -